SEC Form 4 · accession 0001209191-15-027894
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Youssef El Zein
Director · 10% Owner
Period of report
Mar 17, 2015
Accepted (ET)
Mar 19, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2015 | M | 1,250 | $4.80 | A | 487,351 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $4.80 | Mar 17, 2015 | M | 1,250 | D | Apr 1, 2006 | Apr 1, 2015 | Common Stock | 1,250 | 0 | D |
Explanation of responses
- F1This option is fully vested.